Logo for Xenetic Biosciences Inc

Xenetic Biosciences Investor Relations Material

Latest events

Logo for Xenetic Biosciences Inc

Status Update

Xenetic Biosciences
Logo for Xenetic Biosciences

Q4 2024

19 Mar, 2025
Logo for Xenetic Biosciences

Corporate Presentation

9 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Xenetic Biosciences Inc

Access all reports
Xenetic Biosciences, Inc. is a biotechnology company focused on developing immune-oncology therapies and drug delivery technologies. The company specializes in advancing novel treatments for cancer, leveraging its proprietary DNase-based platform designed to improve the effectiveness of chemotherapy and immunotherapy. The company is headquartered in Framingham, Massachusetts, and its shares are listed on the NASDAQ.